Eliot works with Science's news staff in Europe and Asia; edits stories on medical research topics in Washington, D.C.; and writes about patents and other science policy issues. As a reporter for Science, he previously covered topics including radiation health risks, space policy, bioethics, and genome sequencing. Before joining Science, he wrote about politics, health care, and energy for The New Republic in Washington.

More from Author

  • 17 May 1999

    After a 4-day shutdown by the federal government, the Duke University Medical Center in Durham, North Carolina, has been given a green light to start enrolling patients in clinical trials once more.

  • 12 May 1999

    At the behest of federal regulators, Duke University's Medical Center in Durham, North Carolina, shut down most of its government-funded clinical trials this week.

  • 7 May 1999

    With six faculty members crowding the top ranks, Harvard University dominates a list of the 20 most-cited authors of clinical research papers between 1981 and 1998.

  • 5 May 1999

    A former researcher at Genentech Inc. of South San Francisco has testified that he secretly removed a bacterial clone from a lab he had recently left at the University of California (UC), San Francisco, and transferred it to Genentech.

  • 27 Apr 1999

    Low-cost biomedical publishing on the Internet could explode soon, if a plan drafted by the National Institutes of Health (NIH) takes off.

  • 22 Apr 1999

    Smallpox, one of the deadliest viruses to infect humans, just got a reprieve from its own death sentence this week. According to a senior official at the White House, President Bill Clinton has signed a memorandum ordering U.S.

  • 16 Apr 1999

    Dividing along party lines, Congress narrowly approved a Republican budget resolution on 15 April that would limit federal spending to $1.7 trillion in 2000. If strictly enforced, the ceiling would require cuts in domestic programs, including major civilian agency R&D budgets.

  • 15 Apr 1999

    Geneticists are about to get a brand new tool, thanks to a remarkable public-private venture announced today. Ten large, fiercely competitive pharmaceutical companies and the Wellcome Trust, a British charity, are teaming up to spend $45 million to create an archive of human genetic variation.

  • 9 Apr 1999

    WASHINGTON, D.C.--The National Institutes of Health (NIH) is moving ahead slowly on its pledge to fund controversial research on human embryonic stem cells.

  • 24 Mar 1999

    Thomas Cech, a molecular biologist who won the Nobel Prize in chemistry in 1989 for research on RNA's enzyme activity, will be the next president of the Howard Hughes Medical Institute (HHMI) in Chevy Chase, Maryland, the largest private funder of medical research in the United States.